Sebela Site 007 — Anaheim, California

Sebela Site 007 is a clinical research site located in Anaheim, California, United States 92801.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Sebela Site 007 has participated in 1 clinical trials.

Therapeutic areas: Colon Prep for Colonoscopy.

Sponsors: Sebela Pharmaceuticals Development LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Anaheim

Browse all research sites in California · View every site in Anaheim

• Marshall B Ketchum University, Southern California College of Optometry
• University Eye Center at Ketchum Health
• University of California, Irvine Federally Qualified Health Clinic
• West Coast University
• Kaiser Foundation Hospital, Inpatient Pharmacy
• Anaheim Clinical Trials
• Kaiser Permanente-Anaheim
• Research Site
• Advanced Research Center
• Advanced Clinical Research Institute
• GSK Investigational Site
• Pacific Cancer Medical Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sebela Site 007?

Sebela Site 007 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sebela Site 007 conducted?

Sebela Site 007 has 1 clinical trials on record. Their work covers Colon Prep for Colonoscopy.

Is Sebela Site 007 accredited by Crixeo Clinical Trials?

Sebela Site 007 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sebela Site 007?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.